Case Study

Localized Attention On A Global Scale: A Phase III Study In Early Alzheimer's Disease

Source: Worldwide Clinical Trials
Alzheimer's Disease

As a full-service, midsize CRO, Worldwide Clinical Trials can execute global studies while maintaining a boutique approach for our clients and providing individualized attention to clinical sites. In a recent Phase III study focusing on mild cognitive impairment (MCI) and mild Alzheimer’s disease, we worked with 250 sites across 14 countries in North America, Europe, and the Asia-Pacific region. We completed recruitment within 22 months, randomizing more than 1,800 subjects after screening more than 6,000 patients. The global pandemic introduced unanticipated disruption to recruitment, study visits, onsite monitoring, and more. Nevertheless, we persevered and even exceeded expectations in some cases.

VIEW THE CASE STUDY!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader